Search results for " Delivery system"

showing 10 items of 350 documents

Hydroxypropylmethylcellulose films for the ophthalmic delivery of diclofenac sodium

2012

Abstract Objectives The aim of this study was to prepare diclofenac/hydroxypropylmethylcellulose (HPMC) and diclofenac-loaded nanoparticles/HPMC films as potential systems for ocular delivery. Methods Two different concentration of the polymer were used: 1.5 and 2.0% w/v. Chitosan–hyaluronic acid nanoparticles were prepared by the ionotropic gelation technique. Nanoparticles were characterized by transmission electron microscopy, dynamic light scattering, drug encapsulation efficiency and rheological studies. In-vitro drug studies and corneal penetration release studies were carried out. Drug release mechanism was finally evaluated by fitting the Ritger and Peppas equation to data. In addit…

DiclofenacPolymersPharmaceutical ScienceNanoparticleAdministration OphthalmicMethylcellulosePharmacologyPermeabilityDosage formDrug Delivery SystemsHypromellose DerivativesDiclofenacDynamic light scatteringmedicineHyaluronic AcidDosage FormsPharmacologychemistry.chemical_classificationChitosanChemistryAnti-Inflammatory Agents Non-SteroidalDiclofenac SodiumPolymerPermeationHypromellose DerivativesNanoparticlesmedicine.drugNuclear chemistryJournal of Pharmacy and Pharmacology
researchProduct

Controlling the Stealth Effect of Nanocarriers through Understanding the Protein Corona

2016

The past decade has seen a significant increase in interest in the use of polymeric nanocarriers in medical applications. In particular, when used as drug vectors in targeted delivery, nanocarriers could overcome many obstacles for drug therapy. Nevertheless, their application is still impeded by the complex composition of the blood proteins covering the particle surface, termed the protein corona. The protein corona complicates any prediction of cell interactions, biodistribution, and toxicity. In particular, the unspecific uptake of nanocarriers is a major obstacle in clinical studies. This Minireview provides an overview of what we currently know about the characteristics of the protein …

Drug CarriersBiodistributionChemistryPolymeric nanocarriersNanotechnologyProtein Corona02 engineering and technologyGeneral Chemistry010402 general chemistry021001 nanoscience & nanotechnology01 natural sciencesCatalysis0104 chemical sciencesDrug Delivery SystemsDrug deliveryHumansNanoparticlesProtein CoronaNanocarriers0210 nano-technologyAngewandte Chemie International Edition
researchProduct

Nanosistemi polimerici per la veicolazione di farmaci antitumorali o attivi sul sistema nervoso centrale

2014

Drug Delivery Systems Nanoparticelle Micelle SPIONs.
researchProduct

Bisphosphonate prodrugs utilizing endogenous carriers

2016

Targeting of therapeutic agents to a specific site, as well as controlling the rate and time of release, has been intensively investigated and established over the last decades. These studies concerning drug delivery systems led to the formulation of several products that can improve the diffusion across the barriers after drug administration. For this purpose, the development of strategies of novel drug delivery systems for bisphosphonates had taken hold to improve both the bioavailability and safety. Firstly, they have been used for over a century in the branch of industry and later, in the 1960s, in medicine. Bisphosphonates are synthetic compound analogs to the naturally occurring pyrop…

Drug Delivery SystemsOrganic chemistryProdrugsBisphosphonatesBile acidsbisfosfonaatit
researchProduct

Theme issue 5th World Conference on Drug Absorption, Transport and Delivery.

2014

Drug Delivery SystemsPharmaceutical Preparationsbusiness.industryPharmaceutical ScienceMedicineEngineering ethicsNanotechnologyBiological TransportCongresses as TopicbusinessTheme (narrative)Absorption PhysiologicalEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
researchProduct

Core-Shell Arginine-Containing Chitosan Microparticles for Enhanced Transcorneal Permeation of Drugs

2019

Chitosan oligosaccharide (C) was functionalized with L-arginine (A) and short hydrocarbon chains (C-8) to design an amphiphilic copolymer, henceforth CAC(8), leading to microparticles (MPs) consisting of an arginine-decorated hydrophilic shell and inner hydrophobic domains allowing the encapsulation of high amount hydrophobic drugs such as sorafenib tosylate (>10% w/w). L-arginine side chains were selected in order to impart the final MPs enhanced transcorneal penetration properties, thus overcoming the typical biological barriers which hamper the absorption of drugs upon topical ocular administration. The mucoadhesive properties and drug release profile of the CAC(8) MPs (CAC(8)-MPs) were …

Drug3003congenital hereditary and neonatal diseases and abnormalitiesArginineSwinemedia_common.quotation_subjectamphiphilic copolymerPharmaceutical ScienceL-arginineAdministration Ophthalmic02 engineering and technologyArginine030226 pharmacology & pharmacyCorneaChitosan03 medical and health scienceschemistry.chemical_compoundDrug Delivery Systems0302 clinical medicineMucoadhesionSide chainAnimalsskin and connective tissue diseasesProtein Kinase Inhibitorsmedia_commonMucin-3microparticlesDrug CarriersMucinnutritional and metabolic diseasesSorafenibPermeation021001 nanoscience & nanotechnologyCombinatorial chemistryBioavailabilityDrug LiberationmicroparticlechemistrySettore CHIM/09 - Farmaceutico Tecnologico Applicativoocular administrationchitosan0210 nano-technologymucoadhesion
researchProduct

5-Fluorouracil Buccal Tablets for Locoregional Chemotherapy of Oral Squamous Cell Carcinoma: Formulation, Drug Release and Histological Effects on Re…

2010

5-Fluorouracil (5-FU) is currently used for treatment of oral squamous cell carcinoma (OSCC). 5-FU is given by i.v. although the systemic administration is associated with severe toxic effects and no topical formulations of 5-FU for buccal drug delivery have been reported. In this study we would report the development of buccal tablets suitable for direct application of low-doses of 5-FU on cancer lesions. The topical administration could be effective on tumor area while systemic undesired side effects are avoided. Preliminarily, the limited tendency of 5-FU to cross the buccal tissue was established using reconstituted human oral epithelium (RHOE, in vitro) and porcine buccal mucosa (ex vi…

DrugAntimetabolites AntineoplasticPathologymedicine.medical_specialtySwineChemistry PharmaceuticalDrug Compounding5-Fluorouracilmedia_common.quotation_subjectPharmaceutical ScienceApoptosisSettore MED/08 - Anatomia PatologicaLocoregional drug deliveryOral Squamous Cell CarcinomaPermeabilityTissue Culture TechniquesDrug Delivery SystemsSettore MED/28 - Malattie OdontostomatologicheCarcinomaAnimalsHumansMedicinemedia_commonbusiness.industryMouth MucosaAdministration BuccalCancerBuccal administrationmedicine.diseaseReconstituted Human Oral Epitheliumstomatognathic diseasesSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoFluorouracilDrug deliveryCarcinoma Squamous CellSystemic administrationMouth NeoplasmsFluorouracilPorcine buccal mucosaBuccal tabletsbusinessEx vivoTabletsmedicine.drugCurrent Drug Delivery
researchProduct

Medium-Term Culture of Primary Oral Squamous Cell Carcinoma in a Three- Dimensional Model: Effects on Cell Survival Following Topical 5-Fluororacile …

2012

Since the activity of several conventional anticancer drugs is restricted by resistance mechanisms and dose-limiting side-effects, the design of formulations for local application on malignant lesions seems to be an efficient and promising drug delivery approach. In this study, the effect of locally applied 5-FU on cell death was evaluated both in a SCC4/HEK001 model and in a newly proposed 3D outgrowth model of oral squamous cell carcinoma (OSCC). Initially, the optimal drug dose was established by delivery of solutions containing different amounts of 5-FU. The solution containing 1% (w/v) of 5-FU resulted effective in inducing cell death with complete eradication of cell colonies. Buccal …

DrugAntimetabolites AntineoplasticProgrammed cell deathCell Survivalmedia_common.quotation_subjectCellCell Culture TechniquesApoptosisCell CommunicationMatrix (biology)PharmacologyExcipientsDrug Delivery SystemsMicroscopy Electron TransmissionCell Line TumorDrug DiscoverymedicineHumansmedia_commonPharmacologyTUNEL assayDose-Response Relationship Drugbusiness.industryCancerBuccal administrationmedicine.diseasemedicine.anatomical_structureAcrylatesDrug deliveryCarcinoma Squamous CellMethacrylatesMouth NeoplasmsFluorouracilbusinessTabletsCurrent Pharmaceutical Design
researchProduct

Modified Montmorillonite as Drug Delivery Agent for Enhancing Antibiotic Therapy

2021

The appealing properties of surfactant-intercalated Montmorillonites (Organo-montmorillonite, OMt) were successfully investigated to propose an effective drug delivery system for metronidazole (MNE) antibiotic therapy. This represents a serious pharmaceutical concern due to the adverse drug reactions and the low targeting ability of MNE. The non-ionic surfactant Tween 20 was used to functionalize montmorillonite, thus accomplishing the two-fold objective of enhancing the stability of clay dispersion and better controlling drug uptake and release. The adsorption process was performed under different experimental conditions and investigated by constructing the adsorption isotherms through hig…

DrugBiocompatibilitymedia_common.quotation_subjectmontmorillonite; organoclay; metronidazole; surfactant; adsorption; release; drug delivery systemDrug delivery systemGeologyMineralogyGeotechnical Engineering and Engineering GeologyControlled releasechemistry.chemical_compoundMontmorilloniteAdsorptionchemistryPulmonary surfactantChemical engineeringMetronidazoleReleaseSurfactantDrug deliveryOrganoclayAdsorptionOrganoclayQE351-399.2Montmorillonitemedia_commonMinerals; Volume 11; Issue 12; Pages: 1315
researchProduct

Cationic Supramolecular Vesicular Aggregates for Pulmonary Tissue Selective Delivery in Anticancer Therapy

2016

The biopharmaceutical properties of supramolecular vesicular aggregates (SVAs) were characterized with regard to their physicochemical features and compared with cationic liposomes (CLs). Neutral and cationic SVAs were synthesized using two different copolymers of poly(aspartyl hydrazide) by thin-layer evaporation and extrusion techniques. Both copolymers were self-assembled in pre-formulated liposomes and formed neutral and cationic SVAs. Gemcitabine hydrochloride (GEM) was used as an anticancer drug and loaded by a pH gradient remote loading procedure, which significantly increased drug loading inside the SVAs. The resulting average size of the SVAs was 100 nm. The anticancer activity of …

DrugBiodistributionMacromolecular Substancesmedia_common.quotation_subjectSupramolecular chemistryAntineoplastic Agents02 engineering and technology010402 general chemistryHydrazideDeoxycytidine01 natural sciencesBiochemistryGemcitabine Hydrochloridesupramolecular chemistryStructure-Activity Relationshipchemistry.chemical_compoundDrug Delivery SystemsCationsDrug DiscoveryTumor Cells CulturedAnimalsHumansTissue DistributionCationic liposomeRats WistarGeneral Pharmacology Toxicology and Pharmaceuticsvesicular aggregatesCell Proliferationmedia_commonPharmacologyLiposomeDose-Response Relationship DrugMolecular StructurenanoparticleOrganic ChemistryCationic polymerization021001 nanoscience & nanotechnologyGemcitabineRats0104 chemical scienceschemistryBiochemistryantitumor agentliposomeMolecular MedicineDrug Screening Assays Antitumor0210 nano-technologyChemMedChem
researchProduct